AJMC June 29, 2022
The utility of value-based frameworks for payers, providers, and those involved in kidney care delivery was addressed during a session at AHIP 2022.
Kidney care is characterized by complex patient needs that create high risk for payers and providers. Managing this risk while optimizing patient outcomes cannot be achieved with traditional fee-for-service (FFS) models, with public and private payers largely transitioning to the adoption of value-based care programs, noted Terry Ketchersid, MD, MBA, senior vice president and chief medical offficer, Integrated Care Group, Fresenius Medical Care, during a session at AHIP 2022.
Described by Ketchersid as the current focus of value-based care, kidney disease, specifically end-stage renal disease (ESRD), affects 1% of the Medicare population, yet these patients consume approximately...
Today's Sponsors
Today's Sponsor